AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Place of Nasogastric Tube in Uncomplicated Adhesive Small Bowel Obstruction

RecruitingNAAges 18 Years - 85 YearsAllCentre Hospitalier Universitaire, Amiens
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Acute adhesive Small Bowel Obstruction (ASBO) is a public health issue: this is the 3rd cause of hospitalization in Digestive Surgery Departments, 20-30% of patients will be operated, the mortality rate per episode is 3%, the duration of hospitalization is 8 days (up to 16 if resection), and it is associated with a tremendous health care expenses. The working group on ASBO of the World Society of Emergency Surgery suggested two distinct approaches for the management of acute ASBO: non-operative management (NOM) which concerning around 85% of patients and operative management (OM) : * OM: if there is clinical signs of strangulation, peritonitis, bowel ischemia, or if IV CT Scan shows sign of ischemia, strangulation, peritonitis, or if the occlusion persists for more than 72 hours; * NOM in all other cases, including nasogastric tube (NGT), intravenous administration of fluids, and clini

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Presence of an obstruction believed to be secondary to adhesions (abdominal pain and distention, nausea and/or vomiting, no gas and/or stool). * Uncomplicated presentation (no signs of strangulation or peritonitis). * IV CT scan of the abdomen consistent with an uncomplicated ASBO, (performed with a pillow to raise slightly the patient. * Aged 18 or older. * Provision of written, informed consent. * Patient covered by French national health insurance. Exclusion Criteria: * An incarcerated and/or strangulated incisional hernia, colonic obstruction. * No previous abdominal operation. * Obstruction within 4 weeks after a recent operation. * Gastrointestinal neoplasm in progress. * Inflammatory bowel disease in progress. * Abdominal radiotherapy in the last 6 months. * Contraindication to intravenous contrast enhancement for the CT scan, pre-existing risks factors for pneumonitis. * Antecedent of aspiration pneumonia. * Age \> 85 years. * Orientation disturbance. * Bedridden. * Chronic cerebrovascular disease (cerebral infarction sequelae, Parkinson disease etc). * Dementia. * Gastroesophageal disorder (gastroesophageal reflux) * Pregnancy or breastfeeding. * Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision). * Patients unable to provide informed consent. * Age \<18 years.
๐Ÿ’Š

What it tests

  • nasogastric tube
  • NOM without NGT insertion
๐Ÿ“

Where

1 site
Amiens Universitary Hospital
Amiens, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy